David Alter is a primary care provider, practicing in Internal Medicine in Oak Lawn, Illinois. Dr. Alter is rated as an Advanced provider by MediFind in the treatment of Scleredema. His top areas of expertise are Scleredema, Ascites, Type 2 Diabetes (T2D), and Gallbladder Removal.

Franco Rongioletti practices in Milan, Italy. Mr. Rongioletti is rated as an Elite expert by MediFind in the treatment of Scleredema. His top areas of expertise are Scleredema, Papular Mucinosis, Scleromyxedema, and Granuloma Annulare.

Ahmad Jalili practices in Buochs, Switzerland. Mr. Jalili is rated as an Elite expert by MediFind in the treatment of Scleredema. His top areas of expertise are Scleredema, Scleromyxedema, Papular Mucinosis, and Psoriasis.

Jean-david Bouaziz practices in Paris, France. Bouaziz is rated as an Elite expert by MediFind in the treatment of Scleredema. Their top areas of expertise are Scleredema, Papular Mucinosis, Scleromyxedema, Bone Marrow Transplant, and Kidney Transplant.

David Mael is a Rheumatologist in Chicago, Illinois. Dr. Mael is rated as an Experienced provider by MediFind in the treatment of Scleredema. His top areas of expertise are Rheumatoid Arthritis (RA), Necrotizing Vasculitis, Postmenopausal Osteoporosis, and Osteoporosis.

Katina Tsagaris is a Rheumatologist in Atlanta, Georgia. Dr. Tsagaris has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Scleredema. Her top areas of expertise are Scleredema, Systemic Sclerosis (SSc), Scleroma, and Scleroderma.

Joseph Shanahan is a Rheumatologist in Raleigh, North Carolina. Dr. Shanahan is rated as a Distinguished provider by MediFind in the treatment of Scleredema. His top areas of expertise are Scleredema, Scleroma, Systemic Sclerosis (SSc), and Psoriasis. Dr. Shanahan is currently accepting new patients.

Cord Sunderkotter practices in Halle, Germany. Mr. Sunderkotter is rated as a Distinguished expert by MediFind in the treatment of Scleredema. His top areas of expertise are Erysipelas, Scleredema, Cellulitis, and Papular Mucinosis.

Thomas Krieg practices in Frankfurt Am Main, Germany. Mr. Krieg is rated as a Distinguished expert by MediFind in the treatment of Scleredema. His top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Scleredema, Localized Scleroderma, and Thrombectomy.

Robert Lafyatis, MD, is a rheumatologist and is certified in rheumatology by the American Board of Internal Medicine. He is  the Thomas Medsger Professor of Medicine at the University of Pittsburgh School of Medicine. He received his medical degree from University of Cincinnati and completed his residency at Wake Forest School of Medicine, followed by his fellowship at National Institutes of Health. Dr. Lafyatis’s clinical interests include systemic sclerosis (scleroderma) and its complications in the skin and lungs. His research interests include understanding the underlying cause of scleroderma and finding new treatments. Dr. Lafyatis directs the University of Pittsburgh/University of Pittsburgh Medical Center Scleroderma Center and the National Institutes of Health, Center for Scleroderma Research Translation.  He has over 200 peer-reviewed publications and co-authors the Textbook of Rheumatology chapter on Scleroderma Pathogenesis. Dr. Lafyatis is rated as an Advanced provider by MediFind in the treatment of Scleredema. His top areas of expertise are Systemic Sclerosis (SSc), Scleroderma, Pulmonary Fibrosis, Scleroma, and Pancreaticoduodenectomy.

Soumya Chatterjee is a Rheumatologist in Cleveland, Ohio. Dr. Chatterjee is rated as an Advanced provider by MediFind in the treatment of Scleredema. His top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Scleroma, and Sjogren Syndrome.

Laura Hummers is an Associate Professor of Medicine in the Division of Rheumatology. She graduated from the University of Rochester School of Medicine and trained in internal medicine at Thomas Jefferson University. She then pursued her rheumatology fellowship at Johns Hopkins University and has since been on the faculty working at the Johns Hopkins Scleroderma Center since 2003 where she has been Co-Director of the Center. She received her ScM degree through the Graduate Training Program in Clinical Investigation from the Bloomberg School of Public Health in 2010. Dr. Hummers also serves as Clinical Director for the Division of Rheumatology. Dr. Hummers actively participates in a number of clinical trials and clinical investigations at the Scleroderma Center and has a particular interest in predictors of outcomes in scleroderma. She actively manages a large patient practice focused exclusively on scleroderma and related conditions at Johns Hopkins and actively helps to manage the Johns Hopkins Scleroderma Center longitudinal database. She also has specific expertise in other scleroderma-like conditions such as scleromyxedema, scleredema and eosinophilic fasciitis. Dr. Hummers is rated as an Advanced provider by MediFind in the treatment of Scleredema. Her top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Eosinophilic Fasciitis, and Scleroma.

Dr. Elise Ng is as assistant professor of dermatology and the Director of Dermatologic Surgery in the Department of Dermatology at Johns Hopkins. She oversees the Johns Hopkins team of Mohs surgeons across four clinical sites, including the Johns Hopkins Outpatient Center, Greenspring Station, the Medical Pavilion at Howard County, and Sibley Memorial Hospital. She also serves as the Director of the Johns Hopkins Micrographic Surgery and Dermatologic Oncology Fellowship training program and is the clinical co-director of the Melanoma Program at the Sidney Kimmel Comprehensive Cancer Center. Her areas of clinical expertise include Mohs micrographic surgery, complex facial reconstruction following skin cancer surgery, melanoma, cosmetic scar revision, and surgical management of benign and malignant skin lesions. Dr. Ng graduated magna cum laude from Harvard College and was awarded the Harvard College Scholar Award for academic excellence. She received her medical degree from Columbia University College of Physicians and Surgeons and subsequently trained at New York University School of Medicine, one of the nation's top dermatology programs, where she was selected to be chief resident. Following residency, she completed a prestigious fellowship in Mohs micrographic surgery and dermatologic oncology with a focus on advanced reconstruction under the tutelage of one of the leaders in the field at Mount Sinai Hospital in New York. She serves as a reviewer for and her research has been published in premier peer-reviewed journals including Journal of the American Academy of Dermatology and Dermatologic Surgery. Dr. Ng joined the faculty of Johns Hopkins School of Medicine in 2017 and has been consistently recognized as a “Top Doctor” by Baltimore Magazine. Dr. Ng is rated as an Advanced provider by MediFind in the treatment of Scleredema. Her top areas of expertise are Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Melanoma, and Bowen's Disease.

Jonathan Thomas is a Rheumatologist in Texarkana, Texas. Dr. Thomas is rated as an Advanced provider by MediFind in the treatment of Scleredema. His top areas of expertise are Eosinophilia-Myalgia Syndrome, Antisynthetase Syndrome, Rheumatoid Arthritis (RA), and Sjogren Syndrome.

Stavros Savvas is a Rheumatologist in Philadelphia, Pennsylvania. Dr. Savvas is rated as an Advanced provider by MediFind in the treatment of Scleredema. His top areas of expertise are Lupus Nephritis, Dermatomyositis, Rheumatoid Arthritis (RA), and Adult Still's Disease. Dr. Savvas is currently accepting new patients.

Gulzar Merchant is a Rheumatologist in Greenville, South Carolina. Dr. Merchant is rated as an Advanced provider by MediFind in the treatment of Scleredema. Her top areas of expertise are Rheumatoid Arthritis (RA), Rhizomelic Pseudopolyarthritis, Polymyalgia Rheumatica, and Osteoporosis. Dr. Merchant is currently accepting new patients.

Duncan Moore is a Rheumatologist in Chicago, Illinois. Dr. Moore has been practicing medicine for over 11 years and is rated as an Advanced provider by MediFind in the treatment of Scleredema. His top areas of expertise are Systemic Sclerosis (SSc), Scleroderma, Scleroma, and Scleredema.

Dr. Ami Shah is an Associate Professor of Medicine and Director of the Division of Rheumatology at the Johns Hopkins University School of Medicine. Dr. Shah also serves as the Co-Director of the Johns Hopkins Scleroderma Center. Her areas of clinical expertise include rheumatology, particularly scleroderma and Raynaud's phenomenon. She is a graduate of the Massachusetts Institute of Technology and Johns Hopkins University School of Medicine. She completed her internal medicine residency training at Stanford University Hospital & Clinics and rheumatology post-doctoral fellowship at Johns Hopkins. During her fellowship training, she earned her Master of Health Science in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health. Dr. Shah’s clinical practice is focused on the broad spectrum of patients with scleroderma and related disorders, and her expertise includes management of complications such as Raynaud’s phenomenon, digital ischemia, pulmonary hypertension, cardiac dysfunction, myopathy, aggressive skin disease and concomitant cancer. Dr. Shah teaches post-doctoral fellows in her clinic about the evaluation and management of scleroderma. Dr. Shah’s research program has focused on the interface between cancer and autoimmunity in scleroderma, myositis and the newly emerging area of immune-related adverse events due to immune checkpoint inhibitor therapy. In highly collaborative studies, her group has published seminal observations linking cancer with the development of autoimmunity in scleroderma, with implications for cancer screening strategies in this population and the potential to shed insight into the pathogenesis of paraneoplastic rheumatic disease. In addition to her work in cancer and autoimmunity, Dr. Shah has an active research program in other clinical and therapeutic aspects of scleroderma, including early detection of cardiopulmonary complications and improving outcome measures and therapeutics for Raynaud's phenomenon. Dr. Shah also directs rheumatology precision medicine initiatives through the Johns Hopkins Individualized Health (inHealth) Initiative. The division’s program seeks to harness technological resources for comprehensive data collection and harmonization, strengthen novel data analytic approaches including defining unique patient subgroups, and accelerate the incorporation of discoveries into the delivery of clinical care. Dr. Shah has been a recipient of the ACR Research and Education Foundation Clinical Investigator Fellowship Award. In 2018, her research contributions were recognized at the 5th Systemic Sclerosis World Congress with receipt of the Edith Busch Prize for Young Investigators. In 2020, she was honored to receive the prestigious Henry Kunkel Young Investigator Award from the American College of Rheumatology. She is a member of the American College of Rheumatology. Dr. Shah is rated as an Advanced provider by MediFind in the treatment of Scleredema. Her top areas of expertise are Scleroderma, Scleroma, Systemic Sclerosis (SSc), and Scleredema.

Marcus Snow is a Rheumatologist and a Pediatrics provider in Omaha, Nebraska. Dr. Snow is rated as an Experienced provider by MediFind in the treatment of Scleredema. His top areas of expertise are Systemic Sclerosis (SSc), Scleroderma, Rheumatoid Arthritis (RA), and Scleroma. Dr. Snow is currently accepting new patients.

Bonita Libman is a Rheumatologist in Burlington, Vermont. Dr. Libman is rated as an Experienced provider by MediFind in the treatment of Scleredema. Her top areas of expertise are Juvenile Temporal Arteritis, Scleroderma, Systemic Sclerosis (SSc), and Scleroma. Dr. Libman is currently accepting new patients.